Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/10401230500464711PMID 16517453
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Somatic diseases and sleep complaints. An epidemiological study of 3,201 Swedish men.

  2009cited by this paper
• Effect of trazodone on hERG channel current and QT-interval.

  2005cited by this paper
• An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults.

  2005cited by this paper
• A review of the evidence for the efficacy and safety of trazodone in insomnia.

  2005cited by this paper
• Effects of trazodone on EEG sleep and clinical state in major depression

  2005cited by this paper
• A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia.

  2005cited by this paper
• Effects of trazodone on the sleep of depressed subjects — a polygraphic study

  2004cited by this paper
• Inhibition of cardiac HERG potassium channels by the atypical antidepressant trazodone

  2004cited by this paper
• The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium.

  2004cited by this paper
• Chronic insomnia: Effects of tryptophan, flurazepam, secobarbital, and placebo

  2004cited by this paper
• Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia

  2004cited by this paper
• Measuring outcomes in randomized clinical trials of insomnia treatments.

  2003cited by this paper
• Encapsulation and release of the hypnotic agent zolpidem from biodegradable polymer microparticles containing hydroxypropyl-beta-cyclodextrin.

  2003cited by this paper
• Practice parameters for using polysomnography to evaluate insomnia: an update.

  2003cited by this paper
• Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.

  2003cited by this paper
• Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia.

  2002cited by this paper
• Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists.

  2002cited by this paper
• Continuous versus non-nightly use of zolpidem in chronic insomnia: results of a large-scale, double-blind, randomized, outpatient study

  2002cited by this paper
• Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone.

  2002cited by this paper
• Consequences of insomnia and its therapies.

  2001cited by this paper
• Treatment-resistant mood disorders: Sleep abnormalities in treatment-resistant mood disorders

  2001cited by this paper
• Correlates of global sleep dissatisfaction in the German population.

  2001cited by this paper
• New developments for treating sleep disorders.

  2001cited by this paper
• The relationship between psychiatric diseases and insomnia.

  2001cited by this paper
• A psychiatric perspective on insomnia.

  2001cited by this paper
• A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening.

  2001cited by this paper
• Future directions in the management of insomnia.

  2001cited by this paper
• Comparability of sleep disorders diagnoses using DSM-IV and ICSD classifications with adolescents.

  2001cited by this paper
• A Double-Blind Comparative Study of Zolpidem versus Zopiclone in the Treatment of Chronic Primary Insomnia

  2001cited by this paper
• A Preliminary Study of Hormone Replacement Therapy and Psychological Mood States in Perimenopausal Women

  2001cited by this paper
• Insomnia in the elderly: a review for the primary care practitioner.

  2000cited by this paper
• The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach.

  2000cited by this paper
• Eight weeks of non-nightly use of zolpidem for primary insomnia.

  2000cited by this paper
• Meta-analysis of benzodiazepine use in the treatment of insomnia.

  2000cited by this paper
• Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia

  2000cited by this paper
• Zaleplon: a pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomnia.

  2000cited by this paper
• Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.

  2000cited by this paper
• Dose‐response effects of zaleplon as compared with triazolam (0·25 mg) and placebo in chronic primary insomnia

  2000cited by this paper
• Zaleplon improves sleep without producing rebound effects in outpatients with insomnia

  2000cited by this paper
• Prolonged QT interval after trazodone overdose.

  1999cited by this paper
• The effects of trazodone on sleep disturbances induced by brofaromine

  1999cited by this paper
• Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.

  1999cited by this paper
• Reproductive Hormones, Aging, and Sleep

  1999cited by this paper
• Chronic insomnia: a practical review.

  1999cited by this paper
• Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I.

  1999cited by this paper
• Subjective hypnotic efficacy of trazodone and zolpidem in DSMIII–R primary insomnia

  1998cited by this paper
• Comparison of Continuous versus Intermittent Administration of Zolpidem in Chronic Insomniacs: A Double-Blind, Randomized Pilot Study

  1998cited by this paper
• Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy.

  1997cited by this paper
• Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.

  1997cited by this paper
• Nonorganic insomnia in generalized anxiety disorder. 1. Controlled studies on sleep, awakening and daytime vigilance utilizing polysomnography and EEG mapping.

  1997cited by this paper
• Minimal rebound insomnia after treatment with 10-mg zolpidem.

  1997cited by this paper
• Symptom experiences of midlife women: observations from the Seattle Midlife Women's Health Study.

  1996cited by this paper
• Management of primary sleep disorders among elderly persons.

  1995cited by this paper
• Sleep complaints among elderly persons: an epidemiologic study of three communities.

  1995cited by this paper
• Management of primary sleep disorders among elderly persons.

  1995cited by this paper
• Sleep onset insomnia, sleep maintaining insomnia and insomnia with early morning awakening--temporal stability of subtypes in a longitudinal study on general practice attenders.

  1994cited by this paper
• Guidelines for the rational use of benzodiazepines. When and what to use.

  1994cited by this paper
• Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy.

  1994cited by this paper
• Clinical and polysomnographic effects of trazodone CR in chronic insomnia associated with dysthymia

  1994cited by this paper
• A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.

  1994cited by this paper
• Quazepam versus triazolam in patients with sleep disorders: a double-blind study.

  1993cited by this paper
• Pharmacology of benzodiazepine hypnotics.

  1992cited by this paper
• Prescribing Short-Acting Hypnosedatives

  1992cited by this paper
• Issues in the use of benzodiazepine therapy.

  1992cited by this paper
• Emotional and social aspects of cancer pain.

  1992cited by this paper
• Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines

  1991cited by this paper
• Hypnotic Efficacy of Estazolam Compared with Flurazepam in Outpatients with Insomnia

  1991cited by this paper
• Objective measurements of daytime sleepiness and performance comparing quazepam with flurazepam in two adult populations using the Multiple Sleep Latency Test.

  1991cited by this paper
• A multicenter 14-day study of flurazepam and midazolam in chronic insomniacs: general discussion and conclusions.

  1990cited by this paper
• Sleep evaluation in chronic insomniacs during 14-day use of flurazepam and midazolam.

  1990cited by this paper
• Clinical safety of flurazepam and midazolam during 14-day use in chronic insomniacs.

  1990cited by this paper
• Estazolam and Flurazepam: A Multicenter, Placebo‐Controlled Comparative Study in Outpatients with Insomnia

  1990cited by this paper
• Cognitive performance and mood in patients with chronic insomnia during 14-day use of flurazepam and midazolam.

  1990cited by this paper
• Sleep laboratory evaluation of the effects and efficacy of trazodone in depressed insomniac patients.

  1990cited by this paper
• Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation.

  1990cited by this paper
• A comparison of the efficacy, tolerance and residual effects of zopiclone, flurazepam and placebo in insomniac outpatients.

  1990cited by this paper
• Psychomotor performance in chronic insomniacs during 14-day use of flurazepam and midazolam.

  1990cited by this paper
• INCREASED DEEP SLEEP AFTER TRAZODONE USE : A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY IN HEALTHY YOUNG ADULTS

  1990cited by this paper
• Increased deep sleep after trazodone use: a double-blind placebo-controlled study in healthy young adults.

  1990cited by this paper
• Zopiclone versus Flurazepam in Insomnia: Prolonged Administration and Withdrawal

  1990cited by this paper
• Plasma concentrations of flurazepam and midazolam in chronic insomniacs during 14-day use and their relationship to therapeutic effects and next-day performance and mood.

  1990cited by this paper
• Long-term therapeutic use of benzodiazepines. II. Effects of gradual taper.

  1990cited by this paper
• Benzodiazepine hypnotics and insomnia.

  1990cited by this paper
• Pain experience and pain management among hospitalized cancer patients. A clinical study

  1989cited by this paper
• Comparison of the short-acting benzodiazepines midazolam and triazolam with placebo.

  1988cited by this paper
• Efficacy Without Tolerance or Rebound Insomnia for Midazolam and Temazepam After Use for One to Three Months

  1987cited by this paper
• Dose effects of temazepam tablets on sleep.

  1986cited by this paper
• Insomnia and its treatment. Prevalence and correlates.

  1985cited by this paper
• Zopiclone: A Non-Benzodiazepine Hypnotic

  1985cited by this paper
• A multi-center clinical investigation of estazolam: short-term efficacy

  1984cited by this paper
• Incidence of next-day anterograde amnesia caused by flurazepam hydrochloride and triazolam.

  1984cited by this paper
• Comparative study of lormetazepam and flurazepam in the treatment of insomnia.

  1984cited by this paper
• A Comparison of the Hypnotic Activity of Loprazolam, Temazepam and Placebo in General Practice

  1984cited by this paper
• Flurazepam and Temazepam in the Treatment of Insomnia in a General Hospital Population

  1984cited by this paper
• Comparative hypnotic effects of flurazepam, triazolam, and placebo: a long-term simultaneous nighttime and daytime study.

  1984cited by this paper
• Insomnia and its treatment. When are hypnotics justified?

  1984cited by this paper
• Comparative study of lormetazepam and flurazepam in the treatment of insomnia.

  1984cited by this paper
• Short-Term Study of Quazepam 15 Milligrams in the Treatment of Insomnia

  1983cited by this paper
• Evaluation of the Short-Term Treatment of Insomnia in Out-Patients with 15 Milligrams of Quazepam

  1983cited by this paper
• Trazodone enhances sleep in subjective quality but not in objective duration.

  1983cited by this paper

• A review on orexin receptor antagonists in chronic insomnia: a revolutionary approach

  2026cites this paper
• The Evolution of Benzodiazepine Allosteric Modulators: Structural Insights From Historical Milestones to Emerging Innovations in Drug Discovery and Development.

  2025cites this paper
• Uso da trazodona na terapia de indução e transtornos do sono em comparação as zdrugs e benzoadiazepínicos

  2025cites this paper
• Impacts of traumatic brain injury severity and sex on sleep architecture, duration, and fragmentation

  2025cites this paper
• Effect of daridorexant on nighttime wakefulness and next-morning sleepiness: assessing the transition from night to day in insomnia disorder.

  2025cites this paper
• Synthesis of imidazole-fused nitrogen-bridgehead heterocycles catalysed by lipase and their antifungal and antimicrobial bioactivity

  2024cites this paper
• Comparative Analysis of the Sedative and Hypnotic Effects among Various Parts of Zizyphus spinosus Hu and Their Chemical Analysis

  2024cites this paper
• Kalium phosphoricum comp. in patients with neurasthenia: a randomized, double-blind, placebo-controlled clinical trial

  2023cites this paper
• Number, Duration, and Distribution of Wake Bouts in Patients with Insomnia Disorder: Effect of Daridorexant and Zolpidem

  2023cites this paper
• Light therapy in insomnia disorder: A systematic review and meta‐analysis

  2023cites this paper
• Daridorexant, a Recently Approved Dual Orexin Receptor Antagonists (DORA) in Treatment of Insomnia

  2023cites this paper
• The Efficacy of V. odorata Extract in the Treatment of Insomnia: A Systematic Review and Meta-Analysis

  2022cites this paper
• Advancement in the contemporary clinical diagnosis and treatment strategies of insomnia disorder.

  2022cites this paper
• Proteomics Reveals Molecular Changes in Insomnia Patients with More Dreams

  2022cites this paper
• Cost-effectiveness analysis of lemborexant for treating insomnia in Japan: a model-based projection, incorporating the risk of falls, motor vehicle collisions, and workplace accidents

  2022cites this paper
• Development and validation of novel HPLC method for analytical evaluation of Lemborexant in tablet dosage form

  2022cites this paper
• Daridorexant, a recently approved Dual Orexin Receptor Antagonists (DORA) in the treatment of insomnia.

  2022cites this paper
• Neurodoron(R) in patients with neurasthenia -- A randomized, double-blind, placebo-controlled clinical trial

  2022cites this paper
• The Positive Effects of Poria cocos Extract on Quality of Sleep in Insomnia Rat Models

  2022cites this paper
• Electroencephalogram Correlates the Role of Ashwagandha in Sleep and Memory Promoting Effect

  2021cites this paper
• NDT_A_297504 2549..2566

  2021influential citation
• Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapies

  2021cites this paper
• Sleep, Cognition, and Yoga

  2021cites this paper
• Liquid Chromatography — Tandem Mass Spectrometry Method for Quantification of Zolpidem in Human Plasma: Application to Pharmacokinetic Study

  2020cites this paper
• Sleep disorders in traumatic brain injury.

  2020cites this paper
• Effects of Resilience Strength Training on Constructs Associated with Moral Injury among Veterans

  2020cites this paper
• Sleep disorders in traumatic brain injury.

  2020cites this paper
• Safety of lemborexant versus placebo and zolpidem: effects on auditory awakening threshold, postural stability, and cognitive performance in healthy older participants in the middle of the night and upon morning awakening

  2020cites this paper
• Clinician and patient barriers to the recognition of insomnia in family practice: a narrative summary of reported literature analysed using the theoretical domains framework

  2020cites this paper
• Evaluating the role of orexins in the pathophysiology and treatment of depression: A comprehensive review.

  2019cites this paper
• Fatigue and its management in the workplace

  2019cites this paper
• Clonazepam: Indications, Side Effects, and Potential for Nonmedical Use.

  2019cites this paper
• Improving Daytime Functioning, Work Performance, and Quality of Life in Postmenopausal Women With Insomnia: Comparing Cognitive Behavioral Therapy for Insomnia, Sleep Restriction Therapy, and Sleep Hygiene Education

  2019cites this paper
• A Green Protocol for the Synthesis of α ‐Diazo‐ β ‐hydroxyesters and One‐Pot Conversion to β ‐Keto‐Esters and Imidazo[1,2‐ a ]pyridine‐3‐carboxylates

  2019cites this paper
• Basic and applied science interactions in fatigue understanding and risk mitigation.

  2019cites this paper
• Management of side effects during and post‐treatment in breast cancer survivors

  2018cites this paper
• Efficacy of Violet oil, a traditional Iranian formula, in patients with chronic insomnia: A randomized, double-blind, placebo-controlled study.

  2018cites this paper
• Control of Sleep Onset by Shal/Kv4 Channels in Drosophila Circadian Neurons

  2018cites this paper
• Palladium (II) Acetate/Base-Catalyzed Intermolecular Coupling of Imidazo[1, 2-a ]pyridine Esters with Aryl Halides

  2018cites this paper
• Formulation Development and Optimization of Oral Thin Films of Zolpidem Tartarate

  2017cites this paper
• Partial Sleep Deprivation Attenuates the Positive Affective System: Effects Across Multiple Measurement Modalities

  2017cites this paper
• GABAA receptor positive allosteric modulators modify the abuse‐related behavioral and neurochemical effects of methamphetamine in rhesus monkeys

  2017cites this paper
• Sleep Disturbance After TBI

  2017cites this paper
• Paradoxical insomnia in a patient taking zopiclone

  2017cites this paper
• Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study

  2017cites this paper
• Catalyst‐Free, Glycerol‐Assisted Facile Approach to Imidazole‐Fused Nitrogen‐Bridgehead Heterocycles

  2017cites this paper
• A review of trazodone use in psychiatric and medical conditions

  2017cites this paper
• Uptake and Disposition of Select Pharmaceuticals by Bluegill Exposed at Constant Concentrations in a Flow-Through Aquatic Exposure System.

  2017cites this paper
• The Quest for Mindful Sleep: a Critical Synthesis of the Impact of Mindfulness-Based Interventions for Insomnia

  2016cites this paper
• Pharmacological interventions to improve sleep in hospitalised adults: a systematic review

  2016cites this paper
• Assessing the efficacy of melatonin to curtail benzodiazepine/Z drug abuse.

  2016cites this paper
• Effect of adjuvant sleep hygiene psychoeducation and lorazepam on depression and sleep quality in patients with major depressive disorders: results from a randomized three-arm intervention

  2016cites this paper
• The Association between Insomnia and Insomnia Treatment Side Effects on Health Status, Work Productivity, and Healthcare Resource Use

  2015cites this paper
• Risky drug use and effects on sleep quality and daytime sleepiness

  2015cites this paper
• The Effects of Sleep Continuity Disruption on Positive Mood and Sleep Architecture in Healthy Adults.

  2015cites this paper
• Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a randomized, 6-week sleep laboratory trial.

  2015cites this paper
• Sleep disturbances, TBI and PTSD: Implications for treatment and recovery.

  2015cites this paper
• Sleep Hygiene and Recovery Strategies in Elite Soccer Players

  2015cites this paper
• Slow oscillating transcranial direct current stimulation during sleep has a sleep‐stabilizing effect in chronic insomnia: a pilot study

  2015cites this paper
• Farmacología del insomnio: valoración de las distintas opciones

  2015cites this paper
• A Discrete Choice Experiment to Elicit Patient Willingness to Pay for Attributes of Treatment-Induced Symptom Relief in Comorbid. Insomnia.

  2015cites this paper
• Pharmacology for insomnia: consider the options.

  2015cites this paper
• Sleep in traumatic brain injury.

  2015cites this paper
• The Effects of Sleep Continuity Disruption on Positive Mood and Sleep Architecture in Healthy Adults

  2015cites this paper
• Pachymic Acid Enhances Pentobarbital-Induced Sleeping Behaviors via GABAA-ergic Systems in Mice

  2014cites this paper
• Retrospective population cohort study on hip fracture risk associated with zolpidem medication.

  2014cites this paper
• Psychotropic Drug Usage and Human Behaviour During Fire Emergencies

  2014cites this paper
• Sleep disorders in elderly

  2014cites this paper
• Development of experiments involving pharmaceutical manufacturing principles

  2014cites this paper
• Valdoxan (agomelatine) in the Treatment of Depression in Cerebrovascular Diseases (results of the Russian Resonance multicenter naturalistic study)

  2014cites this paper
• The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABAA receptors

  2014cites this paper
• Factors Associated with Long-Term Use of Hypnotics among Patients with Chronic Insomnia

  2014cites this paper
• Discovery of novel insomnia leads from screening traditional Chinese medicine database

  2014cites this paper
• Treatment of attention deficit hyperactivity disorder insomnia with blue wavelength light-blocking glasses

  2013cites this paper
• Psychofarmaca bij de behandeling van

  2013cites this paper
• Development and Optimization of Orally Dissolving Film of Zolpidem Tartarate

  2013cites this paper
• THE PROTECTIVE ROLE OF ESCITALOPRAM ON IMPARED HIPPOCAMPAL NEUROPLASTICITY DURING REM DEPRIVATION

  2013cites this paper
• Psychofarmaca bij de behandeling van slaapstoornissen

  2013cites this paper
• Middle-of-the-Night Hypnotic Use in a Large National Health Plan

  2013cites this paper
• Impact of long term Yoga practice on sleep quality and quality of life in the elderly

  2013cites this paper
• Treatment of ADHD insomnia with blue wavelength blocking glasses

  2013cites this paper
• Evidence-based psychological treatments: an update and a way forward.

  2013cites this paper
• Zolpidem-induced Hallucinations: A Brief Case Report from the Indian Subcontinent

  2013cites this paper
• A WASO sub-group analysis of a 6-month study of eszopiclone 3 mg.

  2012influential citation
• Rediscovering Trazodone for the Treatment of Major Depressive Disorder

  2012cites this paper
• Acute effects of zolpidem extended-release on cognitive performance and sleep in healthy males after repeated nightly use.

  2012cites this paper
• New developments in the treatment of primary insomnia in elderly patients: focus on prolonged-release melatonin

  2012cites this paper
• MCCA Board of Directors

  2012cites this paper
• A rapid and highly sensitive UPLC-MS-MS method for the quantification of zolpidem tartrate in human EDTA plasma and its application to pharmacokinetic study.

  2012cites this paper
• [Valdoxan (agomelatine) in the treatment of depression in patients with cerebrovascular diseases: the results of the Russian multicenter naturalistic study "Resonance"].

  2012cites this paper
• New developments in the treatment of primary insomnia in elderly patients: focus on prolonged-release melatonin

  2012cites this paper
• Effect of Neurexan on the pattern of EEG frequencies in rats

  2012cites this paper
• Maximizing Health and Sleep in the Elderly

  2012cites this paper
• Drugs for insomnia

  2012cites this paper
• Sleep Phenotyping in a Mouse Model of Extreme Trait Anxiety

  2012cites this paper
• Herbal triplet in treatment of nervous agitation in children

  2012cites this paper
• Orexin Receptor Antagonism, a New Sleep-Enabling Paradigm: A Proof-of-Concept Clinical Trial

  2012cites this paper
• Melatonin and its analogs in insomnia and depression

  2012cites this paper
• Risk of Fractures Requiring Hospitalization After an Initial Prescription for Zolpidem, Alprazolam, Lorazepam, or Diazepam in Older Adults

  2011cites this paper
• Therapeutic options in the management of sleep disorders in visually impaired children: a systematic review.

  2011cites this paper